Regulation of X-linked gene expression during early mouse development by Rlim

  1. Feng Wang
  2. JongDae Shin
  3. Jeremy M Shea
  4. Jun Yu
  5. Ana Bošković
  6. Meg Byron
  7. Xiaochun Zhu
  8. Alex K Shalek
  9. Aviv Regev
  10. Jeanne B Lawrence
  11. Eduardo M Torres
  12. Lihua J Zhu
  13. Oliver J Rando
  14. Ingolf Bach  Is a corresponding author
  1. University of Massachusetts Medical School, United States
  2. Massachusetts Institute of Technology, United States
  3. Broad Institute of MIT and Harvard, United States

Abstract

Mammalian X-linked gene expression is highly regulated as female cells contain two and male one X chromosome (X). To adjust the X gene dosage between genders, female mouse preimplantation embryos undergo an imprinted form of X chromosome inactivation (iXCI) that requires both Rlim (also known as Rnf12) and the long non-coding RNA Xist. Moreover, it is thought that gene expression from the single active X is upregulated to correct for bi-allelic autosomal (A) gene expression. We have combined mouse genetics with RNA-seq on single mouse embryos to investigate functions of Rlim on the temporal regulation of iXCI and Xist. Our results reveal crucial roles of Rlim for the maintenance of high Xist RNA levels, Xist clouds and X-silencing in female embryos at blastocyst stages, while initial Xist expression appears Rlim-independent. We find further that X/A upregulation is initiated in early male and female preimplantation embryos.

Data availability

The following data sets were generated
    1. Ingolf Bach
    (2015) Transcriptome of mouse preimplantation development
    Publicly available at the NCBI Gene Expression Omnibus (accession no: GSE71442).
The following previously published data sets were used

Article and author information

Author details

  1. Feng Wang

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  2. JongDae Shin

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  3. Jeremy M Shea

    Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  4. Jun Yu

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  5. Ana Bošković

    Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  6. Meg Byron

    Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  7. Xiaochun Zhu

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  8. Alex K Shalek

    Department of Chemistry and Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, United States
    Competing interests
    No competing interests declared.
  9. Aviv Regev

    Broad Institute of MIT and Harvard, Cambridge, United States
    Competing interests
    Aviv Regev, Senior editor, eLife.
  10. Jeanne B Lawrence

    Department of Cell and Developmental Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  11. Eduardo M Torres

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  12. Lihua J Zhu

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  13. Oliver J Rando

    Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  14. Ingolf Bach

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    For correspondence
    ingolf.bach@umassmed.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4505-8946

Funding

National Institutes of Health (R01CA131158)

  • Ingolf Bach

National Institutes of Health (R01HD080224)

  • Oliver J Rando

National Institutes of Health (DP1ES025458)

  • Oliver J Rando

National Institutes of Health (R01GM053234)

  • Jeanne B Lawrence

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mice were housed in the animal facility of UMMS, and utilized according to NIH guidelines and those established by the UMMS Institute of Animal Care and Usage Committee (IACUC protocol #: A-1940-14).

Copyright

© 2016, Wang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,489
    views
  • 566
    downloads
  • 47
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Feng Wang
  2. JongDae Shin
  3. Jeremy M Shea
  4. Jun Yu
  5. Ana Bošković
  6. Meg Byron
  7. Xiaochun Zhu
  8. Alex K Shalek
  9. Aviv Regev
  10. Jeanne B Lawrence
  11. Eduardo M Torres
  12. Lihua J Zhu
  13. Oliver J Rando
  14. Ingolf Bach
(2016)
Regulation of X-linked gene expression during early mouse development by Rlim
eLife 5:e19127.
https://doi.org/10.7554/eLife.19127

Share this article

https://doi.org/10.7554/eLife.19127

Further reading

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Ruben Sebastian-Perez, Shoma Nakagawa ... Maria Pia Cosma
    Research Article

    Chromocenters are established after the 2-cell (2C) stage during mouse embryonic development, but the factors that mediate chromocenter formation remain largely unknown. To identify regulators of 2C heterochromatin establishment in mice, we generated an inducible system to convert embryonic stem cells (ESCs) to 2C-like cells. This conversion is marked by a global reorganization and dispersion of H3K9me3-heterochromatin foci, which are then reversibly formed upon re-entry into pluripotency. By profiling the chromatin-bound proteome (chromatome) through genome capture of ESCs transitioning to 2C-like cells, we uncover chromatin regulators involved in de novo heterochromatin formation. We identified TOPBP1 and investigated its binding partner SMARCAD1. SMARCAD1 and TOPBP1 associate with H3K9me3-heterochromatin in ESCs. Interestingly, the nuclear localization of SMARCAD1 is lost in 2C-like cells. SMARCAD1 or TOPBP1 depletion in mouse embryos leads to developmental arrest, reduction of H3K9me3, and remodeling of heterochromatin foci. Collectively, our findings contribute to comprehending the maintenance of chromocenters during early development.

    1. Developmental Biology
    Yunfei Mu, Shijia Hu ... Hongjun Shi
    Research Article

    Notch signaling has been identified as a key regulatory pathway in patterning the endocardium through activation of endothelial-to-mesenchymal transition (EMT) in the atrioventricular canal (AVC) and proximal outflow tract (OFT) region. However, the precise mechanism underlying Notch activation remains elusive. By transiently blocking the heartbeat of E9.5 mouse embryos, we found that Notch activation in the arterial endothelium was dependent on its ligand Dll4, whereas the reduced expression of Dll4 in the endocardium led to a ligand-depleted field, enabling Notch to be specifically activated in AVC and OFT by regional increased shear stress. The strong shear stress altered the membrane lipid microdomain structure of endocardial cells, which activated mTORC2 and PKC and promoted Notch1 cleavage even in the absence of strong ligand stimulation. These findings highlight the role of mechanical forces as a primary cue for endocardial patterning and provide insights into the mechanisms underlying congenital heart diseases of endocardial origin.